3,4-methylenedioxyamphetamine has been researched along with Epilepsies, Myoclonic in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Epilepsies, Myoclonic: A clinically diverse group of epilepsy syndromes characterized either by myoclonic seizures or by myoclonus in association with other seizure types. Myoclonic epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sutton, MB | 1 |
| Windischbauer, S | 1 |
| Sutton, EM | 1 |
| Weixler, D | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Epilepsies, Myoclonic
| Article | Year |
|---|---|
Resilience, childhood disability and the Internet--case report.
Topics: Adolescent; Community Participation; Diet, Ketogenic; Disabled Children; Epilepsies, Myoclonic; Foll | 2010 |